Telangiectasis Clinical Trial
Official title:
Long-term Follow-up of Sclerotherapy of Reticular Veins and Telangiectasias
A long-term follow-up cohort study of patients that were assigned in two previous studies to compare the clinical results of sclerotherapy of telangiectasias and reticular veins of lower limbs using 0.2% polidocanol diluted in 70% hypertonic glucose (PDHG) vs 75% hypertonic glucose (HG) alone. All women, previously treated as aforementioned, were invited to be reevaluated regarding late maintenance and pigmentation over two years of follow-up. No new treatments were applied to the cohort.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00406380 -
Effect of Avastin in Juxtafoveal Telangiectasias
|
Phase 3 | |
Completed |
NCT00005386 -
Biobehavioral Determinants of Obesity in Black Women
|
N/A | |
Completed |
NCT00005392 -
Epidemiology of Venous Disease
|
N/A | |
Completed |
NCT01205035 -
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
|
Phase 2 | |
Completed |
NCT01362192 -
Treatment of Lower Extremity Spider Veins With Excel V
|
Phase 4 | |
Completed |
NCT00725244 -
Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias
|
Phase 4 | |
Withdrawn |
NCT02090517 -
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
|
N/A | |
Completed |
NCT02657252 -
Polidocanol Versus Glucose Treatment of Telangiectasia Trial
|
Phase 4 | |
Completed |
NCT02104271 -
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.
|
Phase 2 | |
Completed |
NCT00451763 -
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
|
Phase 3 | |
Recruiting |
NCT00206921 -
Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
|
N/A |